Aripiprazole reverses paliperidone-induced hyperprolactinemia.
Hyperprolactinemia is a common side effect of antipsychotic treatments. Existing alternatives to resolve this problem include decreasing the antipsychotic dose or switching to a different antipsychotic agent. Nevertheless, said modifications can sometimes lead to decompensation of the patient. We report a clinical case of a female patient in whom the combined treatment of 5 mg/day of aripiprazole (5 mg/day) reversed paliperidoneinduced hyperprolactinemia within four weeks.
Short Stay Unit, Hospital de Zamudio, Red de Salud Mental de Bizkaia, 48170 Zamudio, Bizkaia, Spain. nieves.basterrecheizaguirre@osakidetza.net
Nieves
N
Basterreche
Mercedes
M
Zumárraga
Aurora
A
Arrue
Olga
O
Olivas
Wendy
W
Dávila
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000188:drug therapy*; D007555:Isoxazoles / Q000009:adverse effects*; D000068882:Paliperidone Palmitate; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects*; D015363:Quinolones / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D007555:Isoxazoles; D010879:Piperazines; D011743:Pyrimidines; D015363:Quinolones; D000068180:Aripiprazole; D000068882:Paliperidone Palmitate